Risks, Benefits, and Taking Participants’ Values Seriously: The Case of HIV Cure Research

By Robert Steel The introduction and refinement of highly effective antiretroviral treatments has transformed HIV into a manageable chronic condition. Nonetheless, treatment is lifelong, burdening people living with HIV and health systems. So there is interest in a cure. But cure trials can be risky and the medical benefit of potentially being cured is limited […]

Read More…

Euthanasia, palliative opioid use and palliative sedation: A rejoinder

By Thomas David Riisfeldt. One of my recent essays has generated a considerable amount of critique which I was fortunate to be able to explore in my essay ‘A response to critics: Weakening the ethical distinction between euthanasia, palliative opioid use and palliative sedation’. I will briefly comment on some of these points here. I […]

Read More…

The option of assisted dying is good for you even if you don’t want to die

By Ben Colburn I am an academic philosopher. In recent years I have been working with end of life practitioners, using my ideas about the importance of individual autonomy to address some tough questions about the predicaments we face as we approach our deaths. We’ve been trying to work out how to support people’s autonomy […]

Read More…

“But it’s not my fault”: what not to say when confronting medical errors (even if it’s true)

By Daniel Tigard. Healthcare professionals are only human—at least, for now. As such, they are prone to simple oversights, or even occasional acts of gross negligence. What makes errors in medical contexts especially concerning is, of course, that any failure can have devastating effects. Patients come to healthcare facilities needing attention for some ailment and […]

Read More…

The Institute of Medical Ethics (IME) Annual Seminar Competition 2020

The Research Committee of the Institute of Medical Ethics (IME) is currently inviting submissions for the third round of its annual seminar competition (2019/2020). The closing date for applications is Monday 2nd December 2019.  This scheme funds projects in the region of £2,500-£3,500, and it is expected that approximately 3-4 awards will be made. The […]

Read More…

Birth and “Birth”: Why Human Subjects in Artificial Wombs Should be Treated as Neonates

By Nick Colgrove. Recently, I argued that human subjects in artificial wombs are newborns (or, at least, should be treated as newborns). This is because the subject of partial ectogenesis—which has been extracted from a pregnant woman’s body and placed in an artificial womb—is a newborn, full stop. The subject of complete ectogenesis—which is created […]

Read More…